Novartis' spending on research and development by division 2017-2018
Novartis AG's spending on research and development by division in 2017 and 2018 (in billion U.S. dollars)
This statistic shows the expenditure on research and development of pharmaceutical company Novartis from in 2017 and 2018, by business segment. In both years, the company spent around 7.6 billion U.S. dollars for research and development in the Innovative Medicines division.
Novartis AG's spending on research and development by division in 2017 and 2018 (in billion U.S. dollars)
Loading statistic...
| 2017 | 2018 | |
|---|---|---|
| Innovative Medicines | 7.62 | 7.68 |
| Sandoz | 0.77 | 0.81 |
| Alcon | 0.58 | 0.59 |
Source
More information
Statistics on "Novartis"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Novartis' number of full-time employees by division 2013-2014
- Novartis' sales revenue in Spain 2012-2017
- Novartis AG's growth products as percent of pharma revenue 2009-2016
- Value of Novartis' pharmaceuticals exported from Spain 2012-2016
- Value of Novartis' investment in Spain 2012-2016
- Novartis' number of employees in Spain 2012-2017
- Novartis' R & D expenditure in Spain 2012-2016
- Otsuka Pharmaceutical's R&D ratio 2009-2017
- Genentech: spending on research and development
- Genetic drugs: percentage of patents worldwide 2010
- AstraZeneca's expenditure on research and development 2006-2018
- Otsuka Pharmaceutical's factories number 2017, by location
- Patent applications for genetic drugs worldwide 2010
- Otsuka Pharmaceutical's female managers ratio 2014-2017
- LabCorp operating income 2013-2018
- Zoetis research and development expenses 2016-2018
- Opinions on integrating technology into life sciences supply chain management 2018
- Gross sales of Mattel's Hot Wheels brand worldwide 2016-2018
- Connector component market shares 2014, by industry
Statistics on "Novartis"
Related topics
About Statista
